On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge of a range of global health threats.

These diseases – HIV/AIDS, tuberculosis (TB), antimicrobial-resistant enteric infections, and COVID-19 – were estimated to have caused at least 95 million new infections and more than 4 million deaths in 2020 alone.

IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV, tuberculosis, and emerging infectious diseases. Its mission is to translate scientific discoveries into affordable, globally accessible public health solutions.